Patients and healthcare professionals have responded to recent media coverage, which they say misrepresented those receiving treatment with cannabis-based medicines in the UK.
Patients, industry, and the police all celebrated this as an imperfect, but overwhelmingly positive step in the right direction for all concerned, recognising the complexity of the issue and the central tenet that law enforcement should approach interactions with a ‘patients first, suspects second’ mindset.
Its author Richard List QPM, a retired veteran police officer who used to lead the UK’s drugs squad, said himself: “In a liberal democracy, if you’re a patient and you’ve had a controlled drug that’s legitimately prescribed by a doctor, you shouldn’t have to worry about any interference from the police.”
Despite this, it took just days before multiple mainstream media outlets had either mischaracterised the guidance, or ignored it entirely in favour of sensationalist stories painting medical cannabis patients as ‘benefits claimants’ using ‘shocking loopholes’ to obtain ‘super strength cannabis’.
While cannabis stigmatisation in the mainstream press is nothing new, several patients reached out to Cannabis Health to share concerns about this coverage, especially in the wake of long-awaited recognition from law enforcement.
Rupa Shah, Chief Legal and Compliance Officer at UK medical cannabis clinic Releaf, told Business of Cannabis: “It’s frustrating for us… that narrative needs to change.
“We obviously want to promote our services, but when trying to educate and remove stigma, that’s difficult for us because of the unique restrictions on advertising. We are a commercial company, and by virtue of that, it makes it slightly more difficult. Ideally, trade bodies should be working with government and policy makers, but it’s something we’re still waiting on.”
“We’re in a unique position where I can have access to the people who might be able to change the narrative. But we’re still working within a system that is very, very heavily regulated.”
Why accurate coverage matters
Recently published (November 2025) peer-reviewed research from Lindsey Metcalf McGrath and Helen Beckett Wilson, paints a clear picture of the impact both a lack of police education and the continued stigmatisation in the mainstream press have on patients.
The study, ‘Training the police on legalised medical cannabis: lessons in building public trust, reducing harm, and avoiding reputational damage’, found that of the 94 police constable apprentices, all around 18-months into operational duties, 9 in 10 (88%) said they knew ‘little or nothing about prescribed cannabis, with many having been misinformed during training.
The research, which used data from clinics including Releaf, documented cases where untrained officers caused serious harm to patients: one was reported to social services with her fitness as a parent questioned, despite her legal cannabis prescription helping control epileptic seizures to the point where she no longer needed family support to care for her child.
Black patients expressed particular anxiety about police encounters, given differential stop-and-search rates.
“Situations where police handle things incorrectly and insensitively are particularly harmful given the high proportion of people being prescribed cannabis for anxiety disorders,” the researchers noted.
The study also revealed the deeply entrenched prohibitionist attitudes officers bring to cannabis encounters. Before training, when asked to write the first three words that came to mind about ‘cannabis users,’ officers’ responses included ‘baghead’ (pejorative UK slang for a drug user), ‘addict,’ ‘young,’ and ‘illegal.’
The researchers found that officers held ‘prohibitionist beliefs that cannabis possession is always synonymous with criminality’, beliefs they traced directly to their training. One officer stated bluntly: ‘Anyone is getting locked up. It is illegal to possess.’
“Prohibitionist narratives and stereotypes are correlated with pejorative beliefs which result in the stigmatisation of patients,” the study found.
As a prime example of this dynamic, Shah points to a recent case which ended in a formal complaint being brought against a senior police officer over comments linking the smell of cannabis to criminality.
In response, advocacy group PatientsCann UK submitted a formal complaint against senior policing figures, arguing that such statements ignore the legal status of prescribed medical cannabis and could influence frontline policing attitudes.
“If that’s what police officers are bringing to their interactions [with] patients, [that’s a] massive problem,” Shah said.
The encouraging finding was that evidence-based training dramatically shifted both knowledge and attitudes. After a three-hour workshop covering the 2018 regulations, patient experiences, and proper verification procedures, 67% of officers said they knew “a lot” about prescribed cannabis, while use of the term ‘baghead’ dropped from 10 mentions to zero. References to ‘medical’ rose from three to 39.
The November 2025 research concluded that ‘the updating of police training and procedures are crucial step in the implementation of legal reforms’ and that this remains ‘overdue in the UK’, with its absence ‘causing harm to patients and damaging the reputation of the police.’
Misleading media coverage adds another layer of confusion to an already complex implementation challenge, one that will play out across 43 police forces over months and years.
While in relative terms, this story was the most factually accurate, its framing still suggested police were being instructed to be lenient, rather than being given a new multi-stage verification protocol.
Just days later (January 09), the Daily Mail ran a 2000+ word story focused more broadly on the UK’s medical cannabis market, moving well beyond questionable framing into full misrepresentation.
Medical cannabis was legalised on 1 November 2018 under the Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales, and Scotland) Regulations 2018 with cross-party support, and operates within one of the most heavily regulated frameworks in the UK.
Cannabis-based products for medicinal use can only be prescribed by specialist consultants on the General Medical Council’s Specialist Register, GPs cannot prescribe them. All prescribing clinics must be registered with and regulated by the Care Quality Commission, using identical standards to NHS services.
Products must be approved by the Medicines and Healthcare products Regulatory Agency, with import licenses granted by the Home Office. Prescriptions are recorded and tracked through the NHS Business Services Authority.
‘Police told not to arrest’
The guidance establishes verification protocols to distinguish lawful prescriptions from illegal possession. It explicitly states officers should take action if they have justifiable grounds to believe possession is not lawful.
“Justifiable grounds for believing it could be for medical use”
The guidance requires verification of actual lawful prescriptions through documentation, including packaging, dispensing labels, prescription letters, and contacting healthcare providers if needed. This is an evidence-based verification process, not discretionary enforcement.
Images of people smoking joints
The guidance explicitly states: “The smoking of medicinal cannabis is strictly prohibited by the legislation.” Smoking is illegal; vaping is the lawful inhalation method.
“Licensed products – which do not contain the whole plant”
Sativex, the most well-known licensed medical cannabis product, is whole-plant cannabis extract containing high levels of both THC and CBD in a 1:1 ratio.
‘Super-strength’ terminology throughout
As prescribing pharmacist Navinder Singh Dhesi noted on LinkedIn: “The term ‘strength’ is meaningless without pharmacological nuance. Cannabinoid medicines are prescribed with specific cannabinoid profiles, controlled dosing, and clear titration plans.” THC percentage alone doesn’t determine therapeutic effect.
Cherry-picked expert opinion (Sir Robin Murray warning of psychiatric risks)
No mention of the 50,000+ peer-reviewed studies on cannabis therapeutics or UK Medical Cannabis Registry research showing sustained mental health improvements over 24 months in prescribed patients.
As one concerned patient told us: “The article depicts cannabis patients who are ‘signed off work with anxiety and depression’ as being ‘handed out super-strength cannabis’ by clinics, feeding into the narrative that cannabis patients are ‘lazy-stoners’ living off benefits… This is a dangerous and cruel narrative that couldn’t be further from the truth.”
JP Doran, Chief Executive Officer of Crucial Innovations Corp (CINV) and a long-standing advocate for patient-centred medical cannabis regulation, told Business of Cannabis: “Much of the coverage around police interactions and medical cannabis still blurs the line between illegal use and legally prescribed treatment, which doesn’t reflect the reality for patients.
“Medical cannabis in the UK is a regulated, clinician-prescribed therapy used by people living with serious, diagnosed conditions, not a cultural or criminal issue. When this distinction is missed, it reinforces stigma and creates unnecessary stress for patients who are simply trying to manage their health lawfully and with dignity.”
The coordinated nature of this coverage was highlighted by Jack Bradburn, a medical cannabis patient who works 60+ hours weekly as a Gas Emergency Engineer.
He told his MP: “On 6th January 2026, the National Police Chiefs Council approved guidance instructing officers to treat medical cannabis patients as ‘patients first, suspects second’… Four days later, on 10th January, the Daily Mail ran a front-page headline describing legitimate prescriptions as a ‘shocking loophole,’ with coordinated coverage across other outlets using identical framing and data.”
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
__cfduid
1 month
The cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.
__hssrc
session
This cookie is set by Hubspot. According to their documentation, whenever HubSpot changes the session cookie, this cookie is also set to determine if the visitor has restarted their browser. If this cookie does not exist when HubSpot manages cookies, it is considered a new session.
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-advertisement
1 year
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Cookie
Duration
Description
__hssc
30 minutes
This cookie is set by HubSpot. The purpose of the cookie is to keep track of sessions. This is used to determine if HubSpot should increment the session number and timestamps in the __hstc cookie. It contains the domain, viewCount (increments each pageView in a session), and session start timestamp.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Cookie
Duration
Description
_gat
1 minute
This cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.
ac_enable_tracking
1 month
This cookie is set by the Active Campaign. This cookie is used to keep track of the site usage.
YSC
session
This cookies is set by Youtube and is used to track the views of embedded videos.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Cookie
Duration
Description
__hstc
1 year 24 days
This cookie is set by Hubspot and is used for tracking visitors. It contains the domain, utk, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga
2 years
This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid
1 day
This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
hubspotutk
1 year 24 days
This cookie is used by HubSpot to keep track of the visitors to the website. This cookie is passed to Hubspot on form submission and used when deduplicating contacts.
iutk
5 months 27 days
This cookie is used by Issuu analytic system. The cookies is used to gather information regarding visitor activity on Issuu products.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Cookie
Duration
Description
IDE
1 year 24 days
Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
mc
1 year 1 month
This cookie is associated with Quantserve to track anonymously how a user interact with the website.
test_cookie
15 minutes
This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE
5 months 27 days
This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Cookie
Duration
Description
__smSessionId
9 hours
No description
__smVID
1 month
This cookie is set by Sumo. The purpose of the cookie is not yet known.
CONSENT
16 years 8 months 13 days 11 hours
No description
lfuuid
9 years 9 months 13 days 11 hours
Third party (Lead Forensics) cookie which enables us to track visitor behaviour on our site. Tracking is performed anonymously until a user identifies themselves by submitting a form.